Document:

Exhibit
4.12

 

 

Date:
______ 2017

 

To

Mrs./Mr.
[   ]

 

Letter
of Indemnity1

 

The
Company’s remuneration committee and the board of directors resolved on November 6, 2016 and the Company’s general
meeting resolved on December 12, 2016 to grant you this indemnity obligation, in the form acceptable in the Company with respect
to Officeholders, all as set forth in this Letter of Indemnity (hereinafter: “the Indemnity Resolution”).

 

Accordingly,
we hereby inform you that as you are currently serving and/or have been serving and/or may be serving in the future as an Officeholder
in the Company and/or any of its subsidiaries and/or affiliates and/or currently employed and/or were employed and/or may be employed
in the future by the Company and/or any of its subsidiaries and/or affiliates, the Company hereby acknowledges and undertakes
towards you, subject to the provisions of any law, as follows:

 

	1.	Indemnity
    Obligation

 

Subject
to the provisions of the law, the Company hereby undertakes to indemnify you for any liabilities or expenses, as set forth in
section 2 below, for which you will be held liable due to one or more of the following:

 

		(a)	Your
                                         acts and/or anything deriving therefrom by virtue of your employment and/or service as
                                         an Officeholder in the Company and/or any of its subsidiaries and/or affiliates, as applicable,
                                         from time to time, in Israel, the U.S.A. and in any other country or location around
                                         the world.
	 	 	 
		(b)	Your
                                         acts and/or anything deriving therefrom by virtue of your service as an Officeholder,
                                         employee or agent of the Company for another corporation in which the Company directly
                                         and/or indirectly holds securities (hereinafter: “Another Corporation”),
                                         in Israel, the U.S.A. and in any other country or location around the world.

 

Including
for any acts made by you prior to the granting date of this Letter of Indemnity, provided the maximum amount of such indemnity
does not exceed the Maximum Indemnity Amount set forth in section 3 below for all types of liabilities and/or expenses in the
aggregate and with respect to all of the Company’s Officeholders as a whole.

 

In
this Letter of Indemnity:

 

	 	“Officeholder”
    	-	as
    such term is defined in the Companies Law, 5759-1999, including any employee to whom the Company resolves to provide a Letter
    of Indemnity.
	 	 	 	 
	 	“Acts”
                                         or anything 

        deriving
        therefrom”
	-	as
                                         such term is defined in the Companies Law, 5759-1999, including any resolution and/or
                                         omission as well as all acts made by you prior to the date of this Letter of Indemnity
                                         during the terms in which you were employed by the Company and/or any of its subsidiaries
                                         and/or affiliates and/or during the terms in which you served as an Officeholder of the
                                         Company and/or any of its subsidiaries and/or affiliates and/or Another Corporation as
                                         defined above.

        

 

1
This letter is an English translation of the original Hebrew indemnification letter. In the event of interpretive disagreement,
please use the Hebrew indemnification letter.

 

    	 	1	 

     

    

  

		2.	Causes
                                         for Indemnity

 

The
indemnity obligation as set forth in section 1 above will apply to any liability or expense indemnifiable under the law and the
Articles of Association of the Company, as follows:

 

		2.1	Financial
                                         liability imposed on you in favor of another person pursuant to any judgment, including
                                         any settlement confirmed as judgment or an arbitrator’s award which has been confirmed
                                         by the court, directly or indirectly connected to one or more of the Events set forth
                                         in the supplement to this Letter of Indemnity (hereinafter: “the Supplement”)
                                         or any part thereof (hereinafter: “Specified Events”), provided the
                                         Maximum Indemnity Amount for each of the Specified Events shall not exceed the amount
                                         stipulated in the Supplement, linked to the increase in the Consumer Price Index’s
                                         from the execution date of this Letter of Indemnity and until the actual indemnity date,
                                         for any of the Specified Events, on the basis of each Event and each of the Company’s
                                         Officeholders separately (hereinafter: “the Final Liability”);
	 	 	 
		2.2	Reasonable
                                         litigation expenses, including attorneys’ fees, expended by you pursuant to an
                                         investigation or proceedings conducted against you by a competent authority authorized
                                         to hold such investigation or bring such proceedings and which were concluded without
                                         an indictment filed against you and without imposing a financial liability on you in
                                         lieu of criminal proceedings, or which were concluded without filing an indictment against
                                         you but with the imposition of financial liability in lieu of criminal proceedings for
                                         an offense which does not require proof of criminal thought (mens rea); in this
                                         paragraph:

 

“Conclusion
of proceedings without an indictment being filed in a matter for which a criminal investigation was commenced” - means
closing of the file in accordance with Section 62 to the Criminal Procedure Law [Combined Version], 5742-1982 (in this subsection
- “the Criminal Procedure Law”), or stay of proceedings by the Attorney General under Section 231 of the Criminal Procedure
Law;

 

“Financial
liability imposed in lieu of criminal proceedings” - means a financial liability imposed by law as an alternative to
criminal proceedings, including an administrative fine pursuant to the Administrative Offenses Law, 5746-1985, a fine for committing
an offense categorized as a finable offense pursuant to the provisions of the Criminal Procedure Law, monetary sanction or ransom.

 

    	 	2	 

     

    

 

 

		2.3	Reasonable
                                         litigation expenses, including attorneys’ fees, expended by you or charged to you by
                                         a court, in proceedings filed against you by the Company or on its behalf or by another
                                         person, or in a criminal charge from which you will be acquitted, or in a criminal charge
                                         of which you will be convicted for an offense which does not require proof of criminal
                                         thought (mens rea).
	 	 	 
		2.4	Expenses
                                         expended by you in connection with administrative enforcement proceedings concerning
                                         you, including reasonable litigation expenses, including attorneys’ fees.

 

In
that regard:

 

“Administrative
enforcement proceedings” - any proceedings under Chapter H3, H4 or I1 of the Securities Law.

“The
Securities Law” - the Securities Law, 5728-1968, as amended from time to time.

 

		2.5	Payment
                                         to an Injured Party, as set forth in Section 52(54)(a)(1)(a) of the Securities Law (“Payment
                                         to an Injured Party”).
	 	 	 
		2.6	Any
                                         other liabilities or expenses indemnifiable under the Companies Law.

 

Litigation
expenses as set forth in sections 2.2, 2.3 and 2.4 above, hereinafter: “the Litigation Expenses”.

 

	3. 	Indemnity
    Amount

 

		3.1	Aggregate
                                         Indemnity Amount

The
total indemnity amount to be paid by the Company to all the Company’s Officeholders (including any employee to whom the
Company decides to grant a Letter of Indemnity) in the aggregate pursuant to all the Letters of Indemnity issued or as shall be
issued to them by the Company under the Indemnity Resolution (hereinafter: “the Letters of Indemnity”) shall
not exceed an amount equivalent to 25% of the Company’s effective equity, plus all the amounts to be received from the insurance
company, if any, as part of the insurance for the Company’s Directors and Officeholders, taken out or to be taken out in
the future by the Company from time to time for the Final Liability and/or Litigation Expenses and/or Payment to an Injured Party
(hereinafter: “the Maximum Indemnity Amount”). For this purpose “the Company’s effective equity”
- means the amount of the Company’s equity as reflected in its recent consolidated financial statements as of the the payment
date of the Indemnity.

 

It
is hereby clarified that payment of the Indemnity Amount as aforesaid, shall not derogate from your entitlement to receive insurance
proceeds, including with reference to the Specified Events set forth in the Letter of Indemnity insured by an insurance company,
which the Company may receive from time to time in your favor, if any, under any Directors & Officers Liability insurance
taken out by the Company.

 

    	 	3	 

     

    

  

Without
derogating from the provisions of section 5.6 below, it is expressly emphasized that the Company’s payments shall only constitute
an “additional layer” above the total insurance proceeds to be paid by the insurer and/or above any indemnification
from any party other than the Company, to the extent such are paid, provided that you will not receive double compensation for
any liability or expense which is indemnifiable as set forth in section 2 above and that in the event you receive an indemnity
from the Company’s insurer under a Directors & Officers Liability policy or by virtue of any other indemnification agreement,
in the matter of the indemnity, the indemnity shall be provided in the amount of the difference between the amount of the Financial
Liability imposed on you and legal expenses and the amount received under the insurance policy or the other indemnification agreement
in this matter, provided the Indemnity Amount undertaken by the Company does not exceed the Maximum indemnity Amount. In addition,
it is emphasized that this indemnity obligation does not constitute a contract in favor of a third party, including any insurer
and may not be assigned, and the insurer shall not be entitled to demand any participation from the Company in the payment undertaken
by the insurer pursuant to the insurance agreement entered with the insurer, save for the deductible stipulated in such agreement.

 

To
the extent that the total Indemnity Amounts payable by the Company at any time, plus all the Indemnity Amounts already paid by
the Company prior to that date under the Letters of Indemnity, exceed the Maximum Indemnity Amount, then the Maximum Indemnity
Amount or the balance thereof, as the case may be, shall be distributed among the Company’s Officeholders entitled to such
Indemnity Amounts for demands made by them to the Company under the Letters of Indemnity and outstanding prior to such date, in
such manner that the actual Indemnity Amount received by each Officeholder shall be calculated pro rata, to the Indemnity Amount
due to each such Officeholders and the Indemnity Amount due to all such Officeholders in the aggregate, on that date, for their
demands.

 

If
the Company has paid Indemnity Amounts to the Company’s Officeholders in the sum of the Maximum Indemnity Amount, the Company
shall not be liable for any additional Indemnity Amounts, unless payment of the additional Indemnity Amounts is approved by the
Company’s competent organs authorized to duly approve such increase on the payment date of the additional Indemnity Amounts
and subject to an amendment of the Company’s Articles of Association, if required under the law.

 

		3.2	The
                                         Indemnity Amount for Specified Events

Subject
to the aforesaid in section 3.1, the Indemnity Obligation for any of the Specified Events shall be limited, with reference to
each Officeholder in the Company and each Event severally, in the amount of the liability or expense indemnifiable as aforesaid,
but not beyond the Maximum Indemnity Amount with respect to each of the Specified Events.

 

    	 	4	 

     

    

 

 

	4. 	Interim
    Payments

 

Upon
the occurrence of any Event for which you may become entitled to indemnity in accordance with the above, the Company shall make
available to you, from time to time, the amounts of money required to cover the various expenses and other payments involved in
the handling of any legal proceedings against you in connection with such Event, including investigation proceedings, so that
you will not be required to pay or finance such amounts by yourself, all subject to the terms and conditions set forth in this
Letter of Indemnity. It is emphasized that the Company shall not demand any securities from you as condition for the transfer
of the above amounts.

 

In
the event that the Company has paid you, or in your stead, any amounts in the framework of this Letter of Indemnity in connection
with legal proceedings as aforesaid, and it is subsequently found that you were not entitled to any indemnity from the Company
for such amounts, the provisions of section 5.8 below shall apply.

 

	5. 	Terms
    and Conditions of Indemnity

 

Without
derogating from the generality of the foregoing, the indemnity under this Letter of Indemnity is subject to the following terms
and conditions:

 

		5.1	Indemnity
                                         Notice

You
must notify the Company promptly about any legal proceedings and/or investigation by a competent authority, authorized to hold
such investigation or bring such proceedings, commenced or threatened against you in connection with any Event for which indemnity
may apply (collectively and severally referred to as: “the Proceedings”), immediately upon becoming aware of
such Proceedings for the first time (hereinafter: “the Indemnity Notice”) and deliver to the Company and/or
anyone directed by the Company any documents provided to you and/or in your possession in connection with these Proceedings.

 

Failure
to provide the Indemnity Notice as aforesaid shall not release the Company from any of its obligations under this Letter of Indemnity,
save where such non delivery of the Indemnity Notice materially affects the Company’s rights to defend a claim in its name
(where also the Company is sued in such Proceedings) and/or in your name and the scope of such damage.

 

		5.2	Defense
                                         Process

The
Company may assume the handling of your defense against the above Proceedings and/or empower an attorney to handle same to be
chosen by the Company for this purpose (except where such attorney is not acceptable to you based on reasonable grounds). The
Company and/or the said attorney shall act in the framework of the above Proceedings to conclude the same; the Attorney appointed
by the Company shall act and owe fiduciary duties towards you and the Company. In the event that during your defense against such
Proceedings a conflict of interests arises between you and the Company, the said attorney shall notify you of such conflict of
interests and you shall be entitled to appoint an attorney on your behalf to handle your defense and the provisions of this Letter
of Indemnity shall apply to any expenses which may be incurred by you as a result of such appointment of an attorney. The Company
shall not be entitled to conclude such Proceedings by means of settlement and/or arrangement and/or agree to any settlement and/or
arrangement which would result in an obligation on your part to pay amounts for which you would not be entitled to indemnity under
this Letter of Indemnity and for which such amounts would not be paid under any Directors & Officers Liability insurance to
be procured, if any, by the Company and/or any of its subsidiaries and/or affiliates and/or Another Corporation, unless the Company
has obtained your prior written consent for such settlement. Moreover, the Company may not resolve the dispute which is the subject
matter of such Proceedings by arbitration or mediation or reconciliation, without your prior written consent, provided your consent
shall not be withheld except for reasonable grounds to be provided by you to the Company in writing. For the avoidance of doubt,
the Company shall bear all the associated expenses, regardless of whether the dispute is referred for settlement by way of arbitration
or mediation or reconciliation or otherwise.

 

    	 	5	 

     

    

  

Notwithstanding
the foregoing, the Company may not conclude such Proceedings by way of settlement and/or arrangement and/or resolve such Proceedings
by arbitration or mediation or reconciliation in case such involve criminal charges against you, unless you give the Company your
prior written consent. You may refuse to provide such consent as mentioned in this paragraph at your exclusive discretion and
without being required to provide the grounds for your refusal.

 

If
within 7 days after receipt of the Indemnity Notice by the Company, as aforesaid, the Company does not assume the handling of
your defense against these Proceedings, or in case you object the representation by the Company’s attorneys for reasonable
grounds or concern for potential conflict of interests, you may refer your representation to an attorney of your choosing and
the provisions of this Letter of Indemnity shall apply to any expenses incurred by you due to such appointment.

 

		5.3	Cooperation
                                         with the Company

At
the request of the Company, you shall sign any documents empowering the Company and/or any such attorney to handle your defense
against such Proceedings on your behalf and to represent you accordingly.

 

You
shall cooperate with the Company and/or any such attorney and comply with all insurers’ instructions under any Directors
& Officers Liability policy in which the Company and/or you may enter in connection with the defense against the above Proceedings,
in any reasonable manner as shall be demanded of you by any of the above as part of their handling of such Proceedings, provided
the Company or the insurance company, as the case may be, see to the covering of all your expenses in connection therewith, so
that you shall not be required to pay or finance such yourself, all subject to the provisions of section 1 and 3 above.

 

		5.4	Cover
                                         of Liabilities

Regardless
of whether the Company acts in accordance with the provisions of section 5.2 above or not, the Company shall see to the covering
of the liabilities and expenses as set forth in section 2 above, in such manner that you shall not be demanded to pay or finance
such yourself, all without derogating from the indemnity promised to you under the provisions of this Letter of Indemnity and/or
the insurance policy taken out by the Company from time to time, if any, all subject to the provisions of sections 1 and 3 above.

 

    	 	6	 

     

    

 

 

		5.5	Indemnity
shall not Apply in cases of Settlement or Admission

The
indemnity in connection with any Proceedings against you, as provided in this Letter of Indemnity, shall not apply to any amounts
due from you to a claimant as consequence of such settlement or arbitration, unless the Company agrees in writing to such settlement
or to conduct such arbitration, as the case may be; the Company, however, shall not withhold its consent other than for reasonable
grounds.

 

Furthermore,
the indemnity shall not apply in the event you admit a criminal charge for an offense which does not require proof of criminal
thought (mens rea), unless the Company has provided its prior written consent to such admission.

 

		5.6	Indemnity
                                         shall not Apply in cases of Third Party Indemnification or Insurance

The
Company shall not be required to pay any amounts under this Letter of Indemnity for any events whatsoever, to the extent such
amounts were actually paid to your or for you or on your behalf by any means in the framework of the Company’s Directors
& Officers Liability insurance, or any other third party indemnification other than the Company’s.

 

With
reference to the Company’s indemnity obligation for any prior or future acts by you by virtue of your being an Officeholder
and/or your employment by the Company and/or any subsidiary and/or affiliate and/or Another Corporation (collectively and severally
referred to as: “the Liable Corporation”) the following provisions shall also apply:

 

		(a)	The
                                         Company shall not be required to pay any amounts under this Letter of Indemnity which
                                         you shall become entitled to receive and actually receive from the Liable Corporation
                                         in the framework of an insurance policy made by the Liable Corporation and/or pursuant
                                         to an undertaking in advance to indemnify or under a permission to indemnify provided
                                         by the Liable Corporation.
	 	 	 
		(b)	If
                                         your demand to receive indemnity and/or insurance coverage for any acts made by you by
                                         virtue of your service at the Liable Corporation which may be indemnifiable under this
                                         Letter of Indemnity is rejected by the Liable Corporation or the Liable Corporation’s
                                         insurance company, as the case may be, the Company shall pay you under this Letter of
                                         Indemnity amounts to which you may become entitled hereunder, if you become entitled
                                         to such amounts and you shall assign to the Company your rights to receive such amounts
                                         from the Liable Corporation and/or under the Liable Corporation’s insurance policy
                                         and authorize the Company to collect such amounts in your name, to the extent that such
                                         authorization is required for the purpose of complying with the provisions of this section.
                                         In this matter, you hereby undertake to sign any documents which may be demanded by the
                                         Company for assigning such rights and authorizing the Company to collect such amounts
                                         in your name.

 

    	 	7	 

     

    

  

		(c)	For
                                         the avoidance of doubt, it is clarified that nothing in this Letter of Indemnity shall
                                         be interpreted as conferring upon the Liable Corporation and/or any third party any rights
                                         whatsoever towards the Company, including, without derogating from the generality of
                                         the aforesaid, the right to claim and/or demand any payment from the Company as participation
                                         in the indemnity and/or the insurance coverage afforded to your by the Liable Corporation
                                         for your acts in your capacity with the Liable Corporation.

		5.7	Payment
of Indemnity

Upon
your request to receive any payment in connection with an Event under this Letter of Indemnity, the Company shall take all necessary
actions under the law to pay such amount and shall act to procure any required approval in this matter, if any. If an approval
for any such payment is required and such payment is not approved for any reason whatsoever, then such payment or any unapproved
part thereof, shall be subject to the approval of the court and the Company shall act to obtain such approval.

 

		5.8	Return
of Indemnity Amounts Paid

In
the event that the Company has paid you, or in your stead, any amounts in the framework of this Letter of Indemnity in connection
with Proceedings as aforesaid, and it is subsequently found that you were not entitled to any indemnity from the Company for such
amounts, such amounts shall be deemed as a loan provided to you by the Company, that shall bear interest in the minimum rate,
as determined from time to time under the law to avoid any tax liable benefit in the hands of the loan recipient and you shall
be required to repay such loan to the Company, together with value added tax for the interest in accordance with the law, pursuant
to a payment arrangement as determined by the Company (as of the date of signing this Letter of Indemnity such interest rate is
4%), provided such amounts are fully paid to the Company by no later than 6 months after the date on which the Company became
aware that you were not entitled to indemnity for the said amounts.

 

		5.9	Providing
Securities in favor of Insurer

Notwithstanding
that stated above in this Letter of Indemnity (including section 4 above) and since as set forth in section 3.1 above the Company’s
payments constitute an “additional layer” above the insurance proceeds to be paid to you by the insurer, if any, then
upon the occurrence of any Event which may entitle you to indemnity, for which you may be required to incur various expenses and
payments for the handling of legal proceedings conducted against you in this matter and connected to such Event, you are required
to first contact the insurer to receive the funds necessary to cover such expenses and payments. For this purpose, the Company
undertakes to make available to the insurer all the necessary securities demanded by the insurer, if any, in order to receive
such funds, provided that the scope of said securities does not exceed the Maximum Indemnity Amount, as defined below.

 

To
the extent it is subsequently discovered that you were not entitled to receive such amounts, if any, from the insurer, you shall
be obligated to immediately return such amounts to the insurer in order to allow the release of the securities provided by the
Company in favor of the insurer. If you fail to comply with the aforesaid, such securities provided by the Company to the insurer
and realized by the insurer shall be considered as a loan in accordance with the provisions set forth in section 5.8 above, mutatis
mutandis.

 

    	 	8	 

     

    

 

 

	6.  	Indemnity
Period

 

The
Company’s undertakings under this Letter of Indemnity shall indefinitely inure to your benefit and/or to the benefit of
your estate, even following the termination of your employment with the Company and/or your service as Officeholder in the Company
and/or any of its subsidiaries and/or affiliates and/or Another Corporation as defined above, as the case may be, provided such
acts for which such indemnity is provided took place during the course of your employment with the Company and/or your service
as Officeholder in the Company and/or any of its subsidiaries and/or affiliates and/or Another Corporation.

 

	7.	The
                                         Company’s undertakings under this Letter of Indemnity shall be broadly interpreted
                                         and in a manner intending to uphold them and comply, to the extent permitted under the
                                         law, with the purposes of this Letter of Indemnity. In the event of a conflict between
                                         any provision in this Letter of Indemnity and the provisions of any law which cannot
                                         be stipulated against, or which may not be amended or supplemented, such provision of
                                         the law shall prevail, but without derogating from and/or affecting the validity and
                                         effect of the other provisions of this Letter of Indemnity.

 

	8.	This
                                         Letter of Indemnity shall come into effect upon your signing a copy of this Letter where
                                         indicated and delivery of the signed copy to the Company.

 

	9.	Nothing
                                         in this Letter of Indemnity shall be interpreted as derogating from any of the provisions
                                         of the Letter of Exemption granted to you by the Company, if any.
	 	 
	10.	The Supplement hereto constitutes an integral part
hereof.

  

	11.	This
                                         Letter of Indemnity shall be governed by Israeli Law and the competent court in Tel Aviv
                                         shall have exclusive jurisdiction to hear any disputes arising from this Letter of Indemnity.

 

In
witness whereof, the Company has hereunto set its hand:

Date:_________
_______________________________________

Therapix
Biosciences Ltd.

 

I,
the undersigned, hereby acknowledge receipt of this Letter of Indemnity and confirm my agreement to the terms and conditions hereof
including the provisions of section 5.8 above.

__________________________________

[Full
Name and Signature of Indemnitee]

 

    	 	9	 

     

    

  

The
Supplement

 

	 	 	The
    Specified Events	 	Final Liability
    (NIS)2
	1	 	Any
    claim or demand made by a customer, supplier, contractor or any third party that engage in any type of business with the Company,
    its subsidiaries, affiliates or Another Corporation as such term is defined above (collectively and/or severally referred
    to in this Supplement as: “the Company”),
    including with respect to the conducting of negotiations with the above. 	 	5,000,000
	2	 	Any
    claim or demand made in connection with a transaction, regardless of whether such transaction was conducted in the Company’s
    ordinary course of business or not, including for acceptance of credit, sale, lease, transfer or purchase of assets or liabilities,
    including securities and receipt and/or providing an option for such sale, lease, transfer or purchase of assets or liabilities.	 	20,000,000
	3	 	Any
    claim or demand made by employees, consultants, agents or other individuals or an entity employed by, or providing services
    to, the Company in connection with compensation owing to them or damages sustained by them or liabilities incurred by them
    in connection with their employment by the Company or their engagement with the Company, including Events associated with
    employees’ terms of employment and labor relations, including employees’ promotion, processing pension arrangements,
    insurance and savings plans, granting securities and other benefits. 	 	2,000,000
	4	 	Any
        claim or demand concerning a failure to disclose or to a supply any kind of information on the due date for disclosure
        under the law, or in connection with an erroneous or faulty disclosure of such information, to third parties, including
        to the holders of the Company’s securities, in
        Israel, the U.S.A. and/or in any other country around the world or
        to prospective holders of securities, including with reference to an issuance, allocation, distribution, purchase, holding
        or connection to the Company’s securities or any other investment activities involving or affected by the Company’s
        securities. Without derogating from the generality of the aforesaid, this Event shall also apply to a public offering
        of securities pursuant to a prospectus, private offering, exchange tender offer or other offering of securities, in
        Israel, the U.S.A. and in any other country around the world.

                                                                                                             

                                                                                                             

        Any
        claim or demand concerning a failure to disclose or to supply any kind of information on the due date for disclosure under
        the law, or in connection with an erroneous or faulty disclosure of such information to third parties, including to the
        income tax authorities, value added tax authorities, the National Insurance Institute of Israel, the Israeli Investment
        Center, local authorities, the Ministry of the Environment and any other governmental or institutional entities or professional
        or other unions, in Israel, the U.S.A.
        and/or in any other country and/or location.
	 	40,000,000

 

2 The amounts listed below are
linked to the increase in the Consumer Price Index from the execution date of this Letter of Indemnity and until the actual indemnity
date. 

 

    	 	10	 

     

    

 

 

	5	 	Any
    claim or demand concerning any Event, act and/or omission, in
    Israel, the U.S.A. and in any other country around the world arising
    from or connected to the issuance of the Company’s securities to the public or a private issuance (including, without
    limitation, claims based on a prospectus published by the Company, or a disclosure or failure to disclose any details therein,
    or reporting or failure to report any matters following the issuance, or compliance or non-compliance with the provisions
    of any relevant securities laws) and including any claim or demand concerning all matters ought to be disclosed in such prospectus,
    including any draft thereof, occurring prior to the date of such prospectus, or thereafter during the period commencing on
    the date of such prospectus and ending upon conclusion of the subscription period which were not duly disclosed in such prospectus
    as required under the law or in later reporting of the Company (hereinafter: “Misleading
    or Deficient Reporting”), provided that immediately after becoming aware of such
    Misleading or Deficient Reporting in the prospectus, the Officeholder duly acted as required under the law. In this matter,
    “reporting” - including interim reports, immediate reports, financial
    statements and any other reporting required of the Company or the Officeholder under any law.	 	40,000,000
	6	 	Any
    claim or demand instituted on the basis of any actual or alleged cause of action or misuse of any third party intellectual
    property by the Company or anyone on its behalf, including the breach of various patent rights.	 	1,000,000
	7	 	Any
    claim or demand instituted by a lender or creditor or relating to moneys loaned by them, or debts owing to them by the Company.
    	 	35,000,000
	8	 	Any
    claim or demand filed by a third party that sustained an injury or damage to a business or personal property, including loss
    of use of such business or personal property during the course of an act or omission attributed to the Company, or to any
    of its employees, agents, respectively, or other persons operating or purporting to operate on behalf of the Company.	 	1,000,000
	9	 	Any
    claim or demand made directly or indirectly in connection with a full or partial omission by the Company, or its Officeholders,
    directors or employees, in anything relating to payment, reporting, or documentation of documents, to any Israeli authorities
    or federal, state or other  foreign or municipal authorities or any payment required under the laws of the State of Israel
    and any other country, including the payment of income tax, sales, appreciation or transfer taxes, excise, value added tax,
    stamp tax, customs, national insurance, salaries or delay in payment of salaries to employees or other delays, including any
    type of interest and linkage differentials.	 	10,000,000
	10	 	Any
    claim or demand instituted by purchasers, owners, lessors, leasees or other holders of assets or products of the Company,
    or individuals engaged with such products, for loss or damage arising from use of such assets or products.	 	20,000,000

 

    	 	11	 

     

    

  

	11	 	Any
        administrative, public or judicial actions, orders, judgments, claims, demands, letters of claims, instructions, arguments,
        charges, attachments, investigation proceedings, or notices on non compliance or violations from any governmental authorities
        or other entities asserting potential liability or accountability (including enforcement expenses, investigations, governmental
        reactions, cleaning, removal or repair for any damage to natural resources, soil damages, bodily injuries or fines or
        donations, indemnification, recuperation expenses, compensation) resulting from the aforesaid, in Israel or outside Israel
        based on or connected to:

                                                                                     

        (a) 
        Any occurrence of fluids release, discharge, leaking, flooding, spill, disposal, emission, leaching or migration into
        the environment on and/or under and/or above land (hereinafter, collectively: “Pollution”) or hazards
        of Pollutions or exposure to any kind of dangerous, explosive, toxic or radioactive substances, waste or other materials
        that are subject to regulatory duties pursuant to environmental laws, at any location belonging to, operated by, rented
        or managed by the Company.

        

        (b)
        Circumstances creating any kind of violation of environmental laws, environmental licenses or permits or any additional
        authorizations required under the environmental laws.
	 	5,000,000
	12	 	Any
    administrative, public or judiciary acts, orders, judgments, claims, demands, letters of demands, instructions, arguments,
    investigations, proceedings, or notices on non compliance or violations of any governmental authorities or other entities
    asserting non compliance with the provisions of any law, regulation, order, ordinance, rule, custom, directive, licensing
    or judgment by the Company or by the Company’s Officeholders in their capacity in the Company.	 	5,000,000
	13	 	Any
    claim or demand with reference to the restructuring or reorganization of the Company or any related resolution, including
    without derogating from the generality of the foregoing, merger,  split, modification of the Company’s share
    capital, incorporation of subsidiaries, dissolution or sale of subsidiaries to third parties.	 	5,000,000
	14	 	Any
    claim or demand with reference to any resolutions or acts of the Company or any Officeholder in his/her capacity as Officeholder
    of the Company, after conducting examinations and consultations appropriate for such types of resolutions or actions, including
    resolutions adopted at the Company’s board of directors or any of its committees.	 	5,000,000
	15	 	Any
    claim or demand with reference to any expressions, statements, including statements of opinion or position or voting at  general
    meetings of corporations and/or other organs of such corporations by an Officeholder in his/her capacity as Officeholder of
    the Company.	 	3,000,000
	16	 	Any
    claim or demand with reference to any opinion of the Company’s board of directors in the context of a tender offer to
    offerees, as to the feasibility of a special tender offer in accordance with the provisions of Section 329 of the Companies
    Law, 5759 - 1999 or a failure to provide such opinion.	 	10,000,000

 

    	 	12	 

     

    

 

 

	17	 	Any
    claim or demand which refer to any of the Events set forth above, in connection with the Officeholder’s service with
    any of the subsidiaries and/or affiliates of the Company and/or Another Corporation, all in his/her capacity as Officeholder
    and/or employee of any of the above companies. 	 	10,000,000
	18	 	All
    acts associated with the performance of a transaction in the field of insurance or acts that resulted in a failure to procure
    appropriate insurance arrangements, including the engagement with reinsurers and/or agents and/or insurers and/or insureds
    and/or other customers.	 	10,000,000
	19	 	Any
    acts in connection with a distribution, including the purchase of shares of the Company, provided that indemnification for
    such act does not constitute a breach of any law.	 	15,000,000
	20	 	Any
    claim or demand filed in connection with sale or purchase transactions or holding marketable securities for or on behalf of
    the Company.	 	20,000,000
	21	 	Any
    claim or demand instituted in connection with an investment transaction considered and/or made by the Company in any securities,
    conducted in the stages prior to and/or following such investment transaction, for the purpose of entering into the transaction,
    its execution, development, follow-up or supervision.	 	20,000,000
	22	 	Any
    claim and demand instituted by holders of the Company’s securities, including the Company’s shareholders, including
    holders of future securities (including shares) of the Company or creditors of the Company, for breach of the companies laws,
    securities laws or any other law in Israel,
    the U.S.A. and in any other country around the world conferring
    causes of action upon the above.	 	40,000,000
	23	 	Any
    claim or demand instituted in connection with an application to or appointment of a receiver for all or part of the assets
    of the Company and/or its subsidiaries and/or affiliates and/or a dissolution application against the Company and/or its subsidiaries
    and/or affiliates and/or any other proceedings filed for the purpose of settlement or arrangement with the creditors of the
    Company and/or of its subsidiaries and/or affiliates.	 	20,000,000
	24	 	Acts
    in connection with, without limitation and without derogating from the generality of the foregoing, the purchase or sale of
    companies, legal entities or properties, as well as Events, directly or indirectly relating to business antitrusts, including
    restrictive arrangements, monopolies, splits or mergers and any legal or other consequences arising therefrom.	 	20,000,000
	25	 	Any
    claim or demand instituted with reference to any required reporting or notice and/or the failure to provide a report or notice
    under the Companies Law, 5759-1999 and/or the Securities Law, 5728-1968, including the regulations promulgated thereunder,
    or pursuant to any similar foreign laws and regulations,
    in the U.S.A. and in any other country around the world,
    or the applicable rules or directives of any Israeli and/or foreign stock exchange in
    the U.S.A. and in any other country around the world.  	 	40,000,000

 

    	 	13	 

     

    

  

	26	 	Any
    claim or demand instituted in connection with the acts of the Company and/or its subsidiaries and/or affiliates, as shall
    exist from time to time, concerning the Company’s field of activities and operations, as shall be conducted from time
    to time, and including in connection with the research, development, manufacture, commercialization, marketing and/or sale
    of pharmaceuticals and/or medical instruments and/or any act directly and/or indirectly associated with the execution of the
    aforesaid acts, including and without derogating from the generality of the above, in connection with clinical and preclinical
    trials, as well as in connection with actions associated with the promotion, marketing and/or support of products, solutions
    and technologies in the Company’s field of activity.	 	30,000,000
	27	 	Any
    claim or demand instituted in connection with an investment in the Company and/or by the Company in Another Corporation, whether
    prior to and/or following the making of such investment, or the entering into, execution, promotion and/or supervision of
    such investment, including acts in the name of the Company by a director, Officeholder, employee and/or observer of such Other
    Corporation.	 	40,000,000
	28	 	Any
    claim or demand instituted in connection with acts taken with respect to the Company’s intellectual property and the
    protection thereof, including the registration or any claim for rights to such intellectual property and defensing claims
    associated with intellectual property or any claim or demand made with regard to an actual or alleged breach, conversion and
    misuse of the intellectual property rights of any third parties by the Company, including confidential information, patents,
    copyrights, design rights, service marks, trade secrets and misappropriation of ideas by the Company and its subsidiaries
    or affiliates.	 	20,000,000
	29	 	Any
    claim or demand instituted in connection with matters involving the invasion of privacy, participation and/or non-participation
    in board of directors’ meetings and/or due to the voting and/or abstaining from voting at board of directors’
    meetings, approval of the acts of the Company, allegations regarding the failure to exercise business discretion and any claim
    or demand instituted in connection with failures to exercise business discretion and/or a reasonable level of skill, expertize
    and handling in connection with the Company’s business.	 	30,000,000
	30	 	Any
    administrative, regulatory or legal claim or proceedings, acts, orders, suits, demands, letters of demand, instructions, allegations,
    charges, investigations, procedures or notices concerning non-compliance or breach by any government body (in Israel or abroad),
    and without derogating from the generality of the above, including the Office of the Chief Scientist or the Investment Center
    at the Ministry of Industry and Trade, the Antitrust Authority and/or the Securities Authority in Israel and/or the U.S.A.
    and/or in any other country and/or location, the Ministry of Health and/or any competent food and drug administrations in
    Israel, the U.S.A. and/or in any other country and/or location, or of any other person alleging non-compliance with any laws,
    statutes, regulations, orders or decrees of any government and/or regulatory body that apply to the Company, its activities
    and business.   	 	30,000,000
	31	 	Any
    claim or demand, not covered by any of the categories of Events described above, which, under any law, a director or Officeholder
    of the Company may be liable for vis-a-vis any government authority and/or agency, in Israel, the U.S.A. and/or in
    any other country and/or location or vis-a-vis any person or entity, in connection with the acts of such a director
    or Officeholder in his/her capacity.	 	20,000,000

 

 

14EXHIBIT 10.1

 

STOCK
REPURCHASE AGREEMENT

THIS
STOCK REPURCHASE AGREEMENT (this "Agreement") is made and entered into as of the later of the two signature dates
below, by and between The Longview Fund, L.P. ( the "Seller") and Optex Systems Holdings, Inc., a company
incorporated under the laws of the State of Delaware (the "Purchaser or Company").

The
Seller and Purchaser may be referred to hereinafter from time to time individually as a "Party" and collectively
as "Parties".

W
I T N E S S E T H:

WHEREAS,
Seller desires to sell to Purchaser, and Purchaser desires to purchase from Seller, 700,000 shares of Common Stock, par
value US$ 0.001 each, in the Purchaser (the "Shares");

WHEREAS,
Seller acknowledges that it received all information that Seller considers necessary or appropriate to enable the Seller to decide
whether to enter into this Agreement and to consummate the transaction contemplated herein;

WHEREAS,
Seller acknowledges that it is the sole record owner of the Shares; and

WHEREAS,
Seller acknowledges that it has all requisite power to enter into and perform this Agreement, and Seller further acknowledges that
it has taken all necessary corporate action on the part of the Seller, its respective directors and Sellers, necessary for the
authorization, execution, delivery and performance by the Seller of this Agreement and the consummation of the transaction contemplated
herein.

NOW,
THEREFORE, in consideration of the mutual promises, covenants and conditions herein contained, it is hereby agreed as follows:

SECTION
1 THE TRANSACTION

Repurchase
of Shares 

1.1 By executing
this Agreement and a stock power endorsed in blank, Seller is hereby selling to Purchaser, and Purchaser is hereby purchasing from
Seller, the Shares which are free of any third party preemptive or similar rights, and free and clear of any mortgages, liens,
pledges, charges, security interests or any other third party rights (other than any third party rights under the existing Sellers'
Agreement (the "Sellers' Agreement"), to the extent applicable), at a price per share equal to $0.74 totaling an aggregate
gross amount of $518,000 (the "Consideration").

1.2
Upon the later of: (i) five (5) business days following the execution date of this Agreement, and (ii) the receipt
by Purchaser of the original certificate(s) representing the Shares, duly endorsed or accompanied by duly executed stock power(s)
or, in the event such original certificate has been lost, destroyed or is otherwise unavailable for delivery, the lost stock affidavit
in the form attached hereto as Exhibit B, Purchaser shall transfer the Consideration to Seller. The payment of the
Consideration shall be subject to any deduction or withholding (tax or otherwise) required under any applicable law, and any amounts
so deducted or withheld shall be treated for all purposes under this Agreement as having been paid to the Seller by the Purchaser.
If applicable, the Seller will delivered to the Purchaser dully signed W-8 or W-9 forms, as the case may be. The stock certificate(s)
or the lost stock affidavit, as the case may be, will be delivered by Seller to Purchaser by an internationally recognized overnight
courier prepaid to the Purchaser’s corporate address.

 

    

    

    

 

1.3 Seller
hereby represents and warrants to Purchaser, as follows:

(a)
Seller is the sole lawful owner, beneficially and of record, of the Shares, and upon the consummation of the transactions contemplated
in this Agreement, Purchaser will acquire from Seller, good and marketable title to such Shares free and clear of all liens, charges,
encumbrances, debt, restrictions, rights, claims, options to purchase, proxies, voting trusts and other voting agreements, calls
and commitments of any kind.

(b)
As of the consummation of the transactions contemplated in this Agreement, Seller has full and unrestricted legal right, power
and authority to enter into and perform all of its obligations under this Agreement, and to sell and transfer the Shares to Purchaser
as provided herein. This Agreement, when executed and delivered by or on behalf of Seller, shall constitute the valid and legally
binding obligation of Seller, legally enforceable against Seller in accordance with its terms.

(c)
At the time of execution of this Agreement, Seller is not in possession of any material inside information of the Company.

(d) The
execution and delivery of this Agreement and the consummation of the transactions contemplated hereby will not result in a breach
by the Seller of, or constitute a default by the Seller under, any agreement, instrument, decree, judgment or order to which the
Seller is a party or by which the Seller may be bound.

(e) By
reason of the Seller’s business or financial experience or the business or financial experience of the Seller’s professional
advisers who are unaffiliated with the Company and who are not compensated by the Company, the Seller has the capacity to protect
the Seller’s own interests in connection with the sale of the Shares to the Company. The Seller is capable of evaluating
the potential risks and benefits of the sale hereunder of the Shares.

(f) The
Seller has received all of the information that the Seller considers necessary or appropriate for deciding whether to sell the
Shares hereunder and perform the other transactions contemplated hereby. The Seller further represents that the Seller has had
an opportunity to ask questions and receive answers from the Company regarding the business, properties, prospects and financial
condition of the Company and to seek from the Company such additional information as the Seller has deemed necessary to verify
the accuracy of any such information furnished or otherwise made available to the Seller by or on behalf of the Company.

(g) The
Seller acknowledges that the Seller will have no future participation in any Company gains, losses, profits or distributions with
respect to the Shares. If the Shares increase in value by any means, or if the Company’s equity becomes freely tradable and
increases in value, the Seller acknowledges that the Seller is voluntarily forfeiting any opportunity to share in any resulting
increase in value from the Shares.

(h)
The Seller has had an opportunity to review with the Seller’s tax advisers the federal, state, local and foreign tax consequences
of the Repurchase and the transactions contemplated by this Agreement. The Seller is relying solely on such advisers and not on
any statements or representations of the Company or any of its agents. The Seller understands that the Seller (and not the Company)
shall be responsible for the Seller’s tax liability and any related interest and penalties that may arise as a result of
the transactions contemplated by this Agreement. 

 

    

    

    

SECTION
2 - Miscellaneous

2.1 Governing
Law; Jurisdiction. The construction, interpretation and performance of this Agreement shall be governed by the laws of the
State of Delaware. Any and all disputes which may arise between the Parties as a result of or in connection with this Agreement,
its interpretation, performance or breach shall be brought and enforced in the courts of the state of Delaware.

2.2 Successors
and Assigns. The provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors
and administrators of the Parties; provided, however, that no party may assign its rights hereunder without the prior written consent
of the other Parties.

2.3 Entire
Agreement; Amendment. This Agreement, including its preamble and exhibits, and the other documents delivered pursuant thereto
constitute the full and entire understanding and agreement between the Parties with regard to the subject matters hereof and thereof
and supersede all prior agreements and understandings relating thereto. Neither this Agreement nor any term hereof may be amended,
waived, discharged or terminated except by an instrument in writing signed by all the Parties.

2.4 Notices.
All notices and other communications required or permitted to be given or sent hereunder shall be in writing and shall be deemed
to have been sufficiently given or delivered for all purposes if mailed by registered airmail, transmitted by facsimile, or delivered
by hand to the Parties' respective addresses set forth in the signature page hereto. All notices sent by registered mail shall
be deemed to have been received within seven (7) business days of posting. If delivered by hand, upon their delivery.

2.5 Delays
or Omissions. No delay or omission to exercise any right, power or remedy upon any breach or default under this Agreement shall
impair any such right, power or remedy of such holder nor shall it be construed to be a waiver of any such breach or default.

2.6 Waiver
of Default. No waiver with respect to any breach or default in the performance of any obligation under the terms of this Agreement
shall be deemed to be a waiver with respect to any subsequent breach or default, whether of similar or different nature. Any waiver,
permit, consent or approval of any kind or character shall be effective only if made in writing and only to the extent specifically
set forth in such writing. All remedies, either under this Agreement or by virtue of law or otherwise afforded to any holder, shall
be cumulative and not alternative.

2.7 Rights;
Severability. If any provision of this Agreement is held by an arbitrator or a court of competent jurisdiction to be unenforceable
under applicable law, then such provision shall be excluded from this Agreement and the remainder of this Agreement shall be interpreted
as if such provision were so excluded and shall be enforceable in accordance with its terms; provided, however, that in such event
this Agreement shall be interpreted so as to give effect, to the greatest extent consistent with and permitted by applicable law,
to the meaning and intention of the excluded provision as determined by such an arbitrator or court of competent jurisdiction.

2.8 Expenses.
Each part shall pay its own expenses, including legal expenses in connection with the transaction contemplated by this Agreement.

 

    

    

    

2.9 Titles
and Subtitles. The titles of the sections and subsections of this Agreement are for convenience of reference only and are not
to be considered in construing this Agreement.

2.10 Counterparts.
This Agreement may be signed in counterparts, each of which shall be deemed to be an original, and together shall constitute one
and the same instrument. The Parties may execute this Agreement via facsimile.

 

IN
WITNESS WHEREOF, the Parties have executed this Stock Purchase Agreement as of the date first above-mentioned.

 

 

	THE LONGVIEW FUND, L.P.:	 	OPTEX SYSTEMS HOLDINGS, INC.:
	 	 	 
	 	 	 
	By:	 	 	By:	 
	Address:	 	 	Address:	 
	 	 	 	 	 
	Date:	 	 	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]